Proshares Ultra Nasdaq Biotechnology Etf (BIB) Technical Analysis
$67.02▲1.22%
Market is closed - opens 7 PM, 20 Oct 2025
Insights
- Proshares Ultra Nasdaq Biotechnology Etf is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Proshares Ultra Nasdaq Biotechnology Etf stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Proshares Ultra Nasdaq Biotechnology Etf stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Proshares Ultra Nasdaq Biotechnology Etf stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 69.75 | Sell |
Stochastic | 81.53, 84.91 | Sell |
Ultimate Oscillator | 56.43 | Neutral |
Stochastic Relative Strength Index | 81.81, 80.06 | Neutral |
Moving Average Convergence Divergence | 2.45, 2.22 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 65.24 | Buy |
20 | 62.37 | Buy |
50 | 58.6 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 64.98 | Buy |
20 | 63.07 | Buy |
50 | 59.14 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 65.05 | Neutral |
20 | 63.66 | Buy |
50 | 60.5 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 66.88 | Buy |
20 | 66.29 | Buy |
50 | 64.27 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 66.94 | Sell |
20 | 67.01 | Buy |
50 | 65.88 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 71.74 |
Resistance L2 | 70.37 |
Resistance L1 | 68.29 |
Pivot Point | 66.93 |
Support L1 | 64.85 |
Support L2 | 63.49 |
Support L3 | 61.41 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.